These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 6414289)

  • 1. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1980-1982).
    Christensen RL; Triplett DA
    Am J Clin Pathol; 1983 Oct; 80(4 Suppl):633-42. PubMed ID: 6414289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of APTT reagent sensitivity to factor IX and factor IX assay performance. Results from the College of American Pathologists Survey Program.
    Brandt JT; Arkin CF; Bovill EG; Rock WA; Triplett DA
    Arch Pathol Lab Med; 1990 Feb; 114(2):135-41. PubMed ID: 2405809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance in hemostasis: the perspective from the College of American Pathologists proficiency testing program.
    Cunningham MT; Brandt JT; Chandler WL; Eby CS; Hayes TE; Krishnan J; Lefkowitz JB; Olson JD; Stasik CJ; Teruya J; Van Cott EM
    Semin Thromb Hemost; 2007 Apr; 33(3):250-8. PubMed ID: 17427059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lupus anticoagulants on the activated partial thromboplastin time. Results of the College of American Pathologists survey program.
    Brandt JT; Triplett DA; Rock WA; Bovill EG; Arkin CF
    Arch Pathol Lab Med; 1991 Feb; 115(2):109-14. PubMed ID: 1899555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factor VIII (antihemophilic factor) assay results in the 1976 College of American Pathologists Survey Program.
    Harms CS; Triplett DA; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):560-2. PubMed ID: 707422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTH.
    Kasper CK; Aronson DL; Davignon G; Foster P; Hillman-Wiseman C; Lusher JM; Manco-Johnson M; Meade JB; Montgomery RR; Rickles FR
    Thromb Haemost; 1995 Sep; 74(3):987-9. PubMed ID: 8571334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor assay (VIII and IX) results in the College of American Pathologists Survey Program (1976-1979).
    Triplett DA; Kocoshis TA; Harms CS
    Scand J Haematol Suppl; 1980; 37():116-29. PubMed ID: 6787698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory evaluation of factor VIII and factor IX.
    Baglini RL
    Am J Med Technol; 1983 Dec; 49(12):857-62. PubMed ID: 6422755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
    Mischke R; Deniz A; Nolte I
    Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress and problems in hemophilia and von Willebrand's disease.
    Abildgaard CF
    Adv Pediatr; 1984; 31():137-77. PubMed ID: 6440429
    [No Abstract]   [Full Text] [Related]  

  • 14. [Test for detection of hemophilia].
    Poppa C; Enache F; Cernat M
    Stud Cercet Med Interna; 1970; 11(6):521-31. PubMed ID: 5313814
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent advances in the detection of carriers of haemophilia A, B and Von Willebrand's disease.
    Schinco PM; Rizza CR
    Haematologica; 1983; 68(1):124-34. PubMed ID: 6404703
    [No Abstract]   [Full Text] [Related]  

  • 16. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B; Giles A; Samis J; Verbeek K; Mensink E; Novákovà I
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined clotting factor deficiencies: experience at a single hemophilia treatment center.
    O'Brien SH; Ritchey AK; Ragni MV
    Haemophilia; 2007 Jan; 13(1):26-9. PubMed ID: 17212721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory diagnosis of hemophilias].
    Egli H
    Dtsch Med J; 1968 Jul; 19(14):495-9. PubMed ID: 5305712
    [No Abstract]   [Full Text] [Related]  

  • 19. Bedside measurement of factor VIII:C activity in individuals with hemophilia A.
    Kessler CM; Bernstein Z; Ghesani S; Shamsipour Z; Frances C; Zucker ML; LaDuca FM
    Am J Hematol; 1996 Mar; 51(3):181-5. PubMed ID: 8619397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
    Asatiani E; Kessler CM;
    Haemophilia; 2007 Nov; 13(6):685-96. PubMed ID: 17973844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.